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Abstract
Background: Gene-set enrichment analysis is a useful technique to help functionally characterize large gene lists, such as
the results of gene expression experiments. This technique finds functionally coherent gene-sets, such as pathways, that are
statistically over-represented in a given gene list. Ideally, the number of resulting sets is smaller than the number of genes in
the list, thus simplifying interpretation. However, the increasing number and redundancy of gene-sets used by many current
enrichment analysis software works against this ideal.
Principal Findings: To overcome gene-set redundancy and help in the interpretation of large gene lists, we developed
‘‘Enrichment Map’’, a network-based visualization method for gene-set enrichment results. Gene-sets are organized in a
network, where each set is a node and edges represent gene overlap between sets. Automated network layout groups
related gene-sets into network clusters, enabling the user to quickly identify the major enriched functional themes and
more easily interpret the enrichment results.
Conclusions: Enrichment Map is a significant advance in the interpretation of enrichment analysis. Any research project that
generates a list of genes can take advantage of this visualization framework. Enrichment Map is implemented as a freely
available and user friendly plug-in for the Cytoscape network visualization software (http://baderlab.org/Software/
EnrichmentMap/).
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Introduction
High-throughput genomic experiments often lead to the
identification of large gene lists [1,2,3]. Gene lists are typically
defined using statistical methods appropriate to the experimental
design. For instance, a frequently applied method is to score genes
by their differential expression between two biological states (such
as healthy vs. diseased). Especially in more mature fields, like gene
expression microarrays, the statistical models used for gene scoring
are well established [1,4]. For instance, gene expression values are
ranked to identify the top-most list of expressed genes, based on an
arbitrary expression threshold, or a set of gene expression
experiments are clustered, each cluster defining a potentially large
gene list. However, these methods for finding interesting genes
often do not help the interpretation of the resulting gene lists and
the formulation of consistent biological hypotheses from these
results still poses a major challenge for experimentalists. Searching
for sets of predefined functionally related genes (e.g. pathways) that
are enriched in a gene list is a popular method designed to solve
this problem. However, as gene-set collections get larger and more
complex, users may experience longer lists of results and increased
redundancy between sets. We have developed a visualization
method for gene set enrichment results, called Enrichment Map,
which helps quickly find general functional themes in genomics
data. In the next sections, we introduce enrichment analysis, the
gene set redundancy problem and then explain how Enrichment
Map works using typical analysis scenarios.
Enrichment analysis
Early approaches to gene list interpretation relied on choosing a
handful of high scoring genes, and then building rather subjective,
anecdotal interpretations. Enrichment analysis is an automated
and statistically rigorous technique to analyze and interpret large
gene lists using a priori-knowledge [5]. Enrichment analysis assesses
the over- (or under-) representation of a known set of genes (e.g. a
biological pathway) within the input gene list [6,7,8]. If a
statistically significant number of genes from the known set are
present in the gene list, it may indicate that the biological pathway
plays a role in the biological condition under study. This analysis is
repeated for all available known gene-sets, which could number in
the thousands.
Over 60 enrichment analysis methods and tools have been
developed in the last few years [5,9,10]. They mainly differ in (a)
their database of known gene-sets and (b) the statistical method
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review existing approaches for enrichment analysis considering
these two facets.
Mostenrichmenttoolsderivegene-setsfromGeneOntology(GO)
annotations [11], because they are readily accessible for many
organisms and cover many genes, yet many other sources of gene-
sets exist and are used by some tools in addition to GO [7,12,13].
Gene-sets can be defined based on participation in a metabolic or
signaling pathway (e.g. KEGG [14], Reactome [15]), targeting by
gene expression regulators (e.g. microRNA, transcription factors),
protein features such as domains, chromosomal location and
association to specific diseases, stimuli, or genetic perturbations.
Gene-sets from multiple sources are collected in resources such as
MSigDB [13] or WhichGenes [16]. Not all organisms are well
covered bygene-sets andmanytools onlysupport specificorganisms.
Statistical methods to determine enrichment are usually either
threshold-dependent or whole-distribution [9]. Threshold-depen-
dent techniques require the user to input a discrete list of top-
ranking genes, which may require setting a threshold on the gene
scoring statistic. The one-tail Fisher’s Exact Test [17], based on the
hypergeometric distribution, was the first method proposed to address
this problem [18], and continues to be one of the most used testing
methods of this type [19]. These methods are useful for naturally
discrete lists, but have major drawbacks when utilized with
continuous gene scores. Specifically, results may not be stable to
choice of threshold [20], and there is loss of information caused by
treating gene scores in a binary way (they either pass the threshold
or not). On the other hand, whole-distribution methods are
threshold-free, as they test gene-sets by comparing their score
distribution versus the background distribution. For this reason
they are often preferred over threshold-dependent methods for
gene lists associated with a continuous score. GSEA (Gene-Set
Enrichment Analysis) [13], which utilizes the gene rank derived
from differential expression or other statistics, is one of the most
popular techniques in this group, though other whole-distribution
testing models have been proposed [5,9].
The gene-set redundancy problem
The growing number of available gene-sets, due to the increased
availability of functional annotations, makes enrichment analysis a
powerful tool to help researchers gain interesting insights from
their high-throughput data. However, this comes at a cost: as
gene-set collections get larger and more complex, there may be
longer lists of results and increased redundancy between sets.
Redundancy is particularly problematic with gene-sets derived
from hierarchical functional annotation systems, like GO, as
children terms are partially redundant with their parents by
definition. Gene-set redundancy constitutes a major barrier for the
interpretability of enrichment results, limiting the full exploitation
of its analytic power.
This problem can be addressed by modifying either the
statistical test or the gene-sets to minimize the effect of redundancy
and produce more concise enrichment results. Existing methods
usually take advantage of the hierarchical structure of Gene
Ontology to reduce redundancy, a solution that is only effective for
GO or other hierarchically organized gene sets and not applicable
to many others, such as pathways, experimental signatures and
regulator targets. POSOC [21] exploits the GO hierarchy to
merge single sets into clusters, which can then be tested for
enrichment. Ontologizer [22] defines a modified Fisher’s Exact Test
for hierarchical vocabularies, termed the parent-child approach.
Enrichment of a given gene-set is calculated with respect to the
parent gene-set, instead of the list of genes in the experiment (the
experimental universe set), in order to downplay uninformative
child enrichment (i.e. enrichment merely ‘‘inherited’’ from the
parent set enrichment). GOstats [23] and elim [24] adopt a reverse
strategy: child terms (i.e. leaves in the hierarchy) are tested first,
then parent nodes are modified so as not to include the genes
present in their enriched children. Ontologizer tends to penalize
smaller gene-sets, whereas GOstats and elim tend to penalize
larger gene-sets. This problem is overcome by the weight
algorithm [24], which reweights genes based on how many
children gene sets they are part of, but this is however limited to
hierarchical vocabularies and requires using Fisher’s Exact Test.
If test and gene-set modification methods are not completely
satisfactory solutions to the gene-set redundancy problems, what
else is available? A different strategy relies on visualizing the
redundancy relations among gene-sets to help the user recognize
redundancy while they explore enrichment results. Tools such as
Onto-Express [25], the Cytoscape [26] plugin BiNGO [27] and
WebGestalt [28] display the hierarchical structure of enriched GO
terms. This helps identify parent-child relationships between
terms, but the applicability is again confined to hierarchical
vocabularies. Other tools are more flexible. They neglect any a-
priori gene-set structure and compute a similarity score among
gene-sets, capturing inter gene-set redundancy. DAVID
[12,29,30] utilizes fuzzy gene clusters, pre-computed on the basis
of annotation similarity among all genes, to sort enriched gene-sets
into different yet partially overlapping groups; results are then
displayed in a tabular format. Molecular Concept Maps (MCM)
software [31] and the ClueGO [32] Cytoscape plugin offer a
richer visualization solution than DAVID, displaying enriched
gene-sets as a network, where each gene-set is represented as a
node and edges connect similar gene-sets. MCM utilizes the
Fisher’s Exact Test p-value as a similarity score between gene-sets.
The MCM network includes the input gene list together with the
enriched gene-sets. Colors are used to differentiate the gene-set
sources. ClueGO determines gene-set similarity according to
Cohen’s kappa statistic. Gene-sets are then clustered using an
iterative merging approach; nodes, representing enriched gene-
sets, are colored according to cluster membership or alternatively
according to the proportion of up- and down-regulated genes;
node size represents enrichment significance. ClueGO and MCM
are useful, as they offer an expressive and intuitive organization of
gene-sets, applicable to any gene-set source. Unfortunately, all the
tools mentioned so far incorporate only one enrichment test (the
Fisher’s Exact Test) and are not designed to work with enrichments
computed using other methods, limiting their power and
flexibility. Many tools only use GO annotation as a source of
gene-sets, and do not take advantage of the many types of other
useful gene-sets that exist. The landscape of available solutions to
gene-set redundancy is summarized in Table 1.
To overcome the above limitations, we developed the
Enrichment Map visualization method, which organizes gene-sets
into a similarity network, where nodes represent gene-sets, links
represent the overlap of member genes, and node color encodes
the enrichment score. ClueGO and MCM create similar networks,
however, Enrichment Map uses a visual style that we find more
intuitive and offers improved functionality: two different enrich-
ment experiments can be comparatively analyzed by displaying
them in the same map; new query gene-sets (e.g. disease genes,
targets of regulators) can be compared to existing gene-sets post-
analysis; a heat-map can be used to explore the data underlying
the enrichment results (e.g. gene-expression patterns) for any gene-
set; finally, Enrichment Map is modular, enabling use with any
type of enrichment test or gene-set source. Enrichment Map is
implemented as a freely available and open-source plugin for the
Cytoscape network visualization and analysis software [26].
Enrichment Map
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be used to interpret enrichment analysis results using frequently
encountered experimental designs.
Results
To simplify the navigation and interpretation of enrichment
results, we have developed Enrichment Map, a network-based
gene-set enrichment result visualization method. Gene-sets are first
analyzed for enrichment significance using a method of choice,
e.g. GSEA [13], and then organized as a weighted similarity
network, where nodes represent gene-sets and weighted links (i.e.
edges) between the nodes represent an ‘‘overlap’’ score depending
on the number of genes two gene-sets share. Nodes are
automatically arranged so that highly similar gene-sets are placed
close together; these clusters can be easily identified manually and
related to biological functions. Gene-set enrichment results are
graphically mapped to the Enrichment Map: node size represents
the number of genes in the gene-set; edge thickness is proportional
to the overlap between gene-sets, calculated using the Jaccard or
overlap coefficients (see Methods). The enrichment score (specif-
ically, the enrichment p-value) is mapped to the node color as a
color gradient. In a typical enrichment test for a single set of genes
(one-class), node color ranges from white (no enrichment) to red
(high enrichment). In a two-class experiment design, node color
ranges from red (high enrichment in one class e.g. case) to white
(no enrichment) to blue (high enrichment in the second class e.g.
control). In the specific case of a gene expression experiment
where a condition of interest is compared to a baseline control, red
is interpreted as up-regulation and blue as down-regulation.
Figure 1 summarizes the information flow from gene scoring to
Enrichment Map analysis for a typical, two-class experiment.
In the next sections, we give examples of typical analysis
scenarios where Enrichment Map is used to analyze gene-
expression experiments. For simplicity, only Gene Ontology
derived gene-sets are used, although any gene-sets can be used
in practice. Use case 1 presents the most basic application of
Enrichment Map, the analysis of a two-class experiment. We
analyze a gene expression data set of MCF7 breast cancer cells, in
presence or absence of estrogen treatment at 24 hours of culture.
In Use case 2, we compare the estrogen response at two time-points,
12 and 24 hours, to evaluate changes over time. In Use case 3,w e
analyze a gene expression study of colon cancer and use the query
set feature of Enrichment Map to investigate the relationship
between the gene expression signature and known genes associated
with colon cancer.
Use case 1: One enrichment (estrogen treatment of
breast cancer cells)
Here, we analyzed the changes in gene expression associated
with estrogen treatment of a breast cancer cell line (MCF7) at
24 hours of culture [33]. Enrichment results were generated after
scoring genes for differential expression using the t-test statistic,
comparing the estrogen-treated versus the untreated samples.
GSEA was then used to find enriched GO gene-sets in up- or
down-regulated genes. Only gene-sets passing conservative
significance thresholds (p-value,0.001, False Discovery Rate
(FDR),5%) were selected for display in the Enrichment Map,
resulting in 156 total gene-sets (out of 2378) significantly enriched
in treated (148 gene-sets) or untreated cells (8).
The output of GSEA, like many other enrichment methods,
consists of a table of gene-sets and their enrichment statistics. This
organization is not helpful for enrichment interpretation if too
many gene-sets pass the significance threshold, as is the case here.
Although the table can be ranked according to enrichment
significance (nominal p-value, FDR, or other scores, in the case of
GSEA), it is difficult to identify gene-sets belonging to a common
functional group, because they are typically scattered throughout
the table. To demonstrate this problem, multiple microtubule
cytoskeleton-related gene-sets are highlighted in the enrichment
table for estrogen-treated cells (Table S1, first tab).
A simple approach to this problem consists of visualizing
enriched GO gene-sets according to the hierarchical relations
defined in the ontology (Figure 2). The resulting network is
composed of several, disconnected sub-networks (i.e. clusters).
These are not interconnected because gene-sets failing the












POSOC [21] Modified gene-sets None
Ontologizer [22] Modified test None
GOStats [23] Modified gene-sets None
elim [23] Modified gene-sets None
weight [24] Modified test None
OntoExpress [25] None Hierarchical ¤
BiNGO [27] None Hierarchical
WebGestalt [28] None Hierarchical
DAVID [12,29,30] None Table ¤
MCM [31] None Network ¤
ClueGO [32] None Network
Enrichment Map None Network ¤¤ ¤
Gene-set redundancy correction methods typically utilize modified gene-sets (Modified gene-sets) or rely on a modified enrichment test (Modified test), but usually require
hierarchically structured gene-sets; consequently, they usually do not support gene-sets from resources other than Gene Ontology. Other methods offer different types
of visualization support, adopting a hierarchical, tabular or network organization of gene-sets. These methods usually allow a broader choice of gene-set sources and
enrichment tests. The table also indicates whether the method supports comparison of different enrichment results.
doi:10.1371/journal.pone.0013984.t001
Enrichment Map
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network size, which otherwise would be too large for visualization
purposes. Clusters typically map to one or a few functional groups,
as displayed by the manually added annotation labels in Figure 2,
hence they can be successfully used to summarize enrichment
results. However, gene-sets relating to the same biological function
(e.g. Microtubule cytoskeleton) but defined in different GO partitions
(e.g. Cellular Component and Biological Process) are systematically split
into different clusters. In a few cases, this occurs even for
functionally related gene-sets from the same GO partition (e.g.
tRNA Processing from Molecular Function).
The Enrichment Map for the same data displayed in Figure 3
overcomes these problems. Gene-sets are organized according to
their mutual overlap. Minimal editing, such as minor repositioning
of nodes and removal of few exceedingly generic gene-sets (e.g.
Protein Complex Assembly, Biopolymer Catabolism), was done to optimize
the map layout. Clusters were manually circled and labeled to
highlight the prevalent biological functions among a set of related
gene-sets. Functionally related gene-sets are highly connected, to a
larger extent than in the purely hierarchical visualization, as
exemplified in the case of Microtubule cytoskeleton (Figure 4). Most
importantly, the overall functional ‘‘landscape’’ fits with the known
role of estrogen hormones as activators of cell proliferation [34]. In
fact, gene-sets enriched in estrogen-treated cells (in red) relate to
increased protein synthesis and RNA processing (left side of the
map) and to the execution and regulation of mitotic cell cycle
(right side of the map). Gene-sets found enriched in untreated cells
(blue) constitute a minor portion of the map and relate to
membrane and cell adhesion (namely, MHC-II receptors, tight
junctions and lipid transport). The down-regulation of these
functions may have a role in supporting proliferation or it may be
associated with relatively undifferentiated cellular states.
The approach described in this use-case can be applied to any
genomic experiment generating a ranked list of genes. For
example, genes can be ranked by their likelihood of being
regulated by a given transcription factor, according to ChIP-chip
or ChIP-seq experiments (Chromatin Immunoprecipitation of genomic
DNA followed by chip hybridization or sequencing) and then
GSEA, or any whole-distribution method, can be used to test
gene-set enrichment in top-ranking genes.
Use case 2: Two enrichments (estrogen treatment of
breast cancer cells)
Enrichment Map can be used to analyze experiments with more
complex designs than the basic two-class described above. In the
previous use case, gene expression was analyzed looking for
changes associated with estrogen treatment at 24 hours of culture.
Here we evaluate differences in the estrogen response kinetics by
additionally considering gene expression enrichment at 12 hours
of culture. Genes were scored for differential gene expression (t-test)
by comparing treated and untreated cells at matching culture
time-points (12 and 24 hours, respectively). GSEA was used to find
enriched GO gene-sets in up- or down-regulated genes, as in the
previous use case. Applying the same conservative significance
thresholds (p-value,0.001, FDR,5%), 188 total gene-sets (out of
2378) were found significantly enriched in treated (179) or
untreated cells (9). The enrichment map was generated by
mapping the 12 hour enrichment to the node center and the
24 hour enrichment to the node border (Figure 5). This two-
enrichment visualization is useful, as we can see gene-set groups
that have the same (all red or all blue) or different enrichment
across the two data sets. It is immediately apparent that the
agreement between the 12 and 24 hours estrogen response is very
high - most nodes are all one color and no nodes are both blue and
red, which would indicate a gene-set with opposite enrichment in
the two time points. In certain cases there are nodes that are
significantly enriched at one time-point, but not at the other.
Figure 1. From ranked gene lists to the enrichment map. High-throughput genomic experiments often output large gene lists, which are
typically ranked according to a statistic measuring difference in one experimental condition versus another. Ranked lists are analyzed for enrichment
in known sets of functionally related genes (e.g. pathways) from publicly accessible databases. An enrichment map is drawn, representing the
enrichment results as a network of gene-sets (nodes) related by their similarity (edges), with enrichment significance encoded by the node color
gradient, where color intensity represents significance and color hue (red / blue) represents the class (i.e. biological condition) of interest. Node size
represents the gene-set size and edge thickness represents the degree of overlap between two gene-sets.
doi:10.1371/journal.pone.0013984.g001
Enrichment Map
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are present in most of the functional groups. These results suggest
that the transcriptional response to estrogen treatment is globally
stronger at 24 hours and that the functional groups induced or
repressed are essentially the same. Further, the four clusters
relating to DNA metabolism, Cell cycle, Microtubule cytoskeleton
and Ubiquitin-dependent protein degradation present an interest-
ing pattern: gene-sets relating to DNA synthesis (such as Replication
fork, DNA polymerase activity) are characterized by stronger
enrichment at 12 hours, whereas gene-sets relating to G2/M
phase components and processes (such as Chromosome condensation,
Spindle and Anaphase Promoting Complex (APC)-dependent protein
degradation) prevail at 24 hours. First, we investigated if differences
in enrichment significance at 12 and 24 hours are consistent with
differential gene expression patterns, utilizing heat-maps generated
by the Enrichment Map software. The APC-dependent protein
degradation (GO:0031145, full name: Anaphase-promoting com-
plex-dependent proteasomal ubiquitin-dependent protein catabol-
ic process) gene-set is characterized by a markedly stronger
induction after estrogen treatment at 24 compared to 12 hours
(Figure 6, left pane), which is consistent with enrichment results.
We next investigated a gene-set exhibiting the opposite enrich-
ment pattern, Replication Fork (GO:0005657) (Figure 6, right pane).
Gene expression in estrogen-treated cells is moderately higher at
24 than 12 hours, but there is a comparable increase in the
untreated cell expression levels. Since enrichments were computed
by comparing estrogen treated and untreated cells at the same
time-point, the different enrichment observed for DNA metabo-
Figure 2. Hierarchical visualization of enrichment results for estrogen treatment of breast cancer cells. Hierarchical organization of GO
gene-set enrichment results for estrogen-treated compared to untreated breast cancer cells at 24 hours of culture. Nodes represent gene-sets and
edges represent GO defined relations (Is-a, Part-of, Regulates). Gene-sets that did not pass the enrichment significance threshold are not shown.
Nodes are colored according to enrichment results: red represents enrichment in estrogen-treated cells (i.e. up-regulation after estrogen treatment),
whereas blue represents enrichment in untreated cells (i.e. down-regulation after estrogen treatment). Color intensity is proportional to enrichment
significance. Since conservative thresholds were used to select gene-sets, most of the node colors are intense (corresponding to highly significant
gene-sets). Subnetworks (i.e. clusters) are annotated according to the corresponding function. The acronym in brackets represents the specific GO
ontology the gene-sets belong to: Molecular Function (MF), Cellular Component (CC), Biological Process (BP). Microtubule cytoskeleton (purple
labels) and tRNA processing (green labels) were highlighted to show absence of connections between related gene-sets.
doi:10.1371/journal.pone.0013984.g002
Enrichment Map
PLoS ONE | www.plosone.org 5 November 2010 | Volume 5 | Issue 11 | e13984Figure 3. Enrichment map for estrogen treatment of breast cancer cells at 24 hours of culture. Themap displays theenrichedgene-sets in
estrogen-treated vs. untreated breast cancer cells at 24 hours of culture. As in Figure 2, red node color represents enrichment in estrogen-treated cells
(i.e.up-regulationafterestrogentreatment),whereasbluerepresentsenrichmentinuntreatedcells(i.e.down-regulation afterestrogentreatment);color
intensity is proportional to enrichment significance. Clusters of functionally related gene-sets were manually circled and assigned a label.
doi:10.1371/journal.pone.0013984.g003
Figure 4. Zoom in of the microtubule cytoskeleton cluster in the 24 hours estrogen treatment enrichment map. Cytoskeleton-related
gene-sets from different GO partitions, such as Spindle (CC) and Microtubule-based process (BP) have been grouped together, unlike in the purely
hierarchical visualization in Figure 2. As in the previous figures, red node color represents enrichment in estrogen-treated cells (i.e. up-regulation after
estrogen treatment), whereas blue represents enrichment in untreated cells (i.e. down-regulation after estrogen treatment); color intensity is
proportional to enrichment significance.
doi:10.1371/journal.pone.0013984.g004
Enrichment Map
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gene expression levels in untreated cells. This suggests that G2/M
phase execution could be more dependent on estrogen signaling
than G1 phase, at least for MCF7 breast cancer cells.
To evaluate the effect of alternative statistics for measuring
differential gene expression on enrichment results, we repeated the
analysis using the ratio of class means instead of the t-test statistic.
Although more gene-sets were found enriched, the enrichment
map clusters were globally the same, but characterized by noisier
patterns (Text S1). For this reason, the ratio of class means was not
used for the final analysis. This also demonstrates the utility of
Enrichment Map in guiding the choice of parameters and
statistical tests for enrichment analysis.
Use case 3: query set post-analysis (early onset colon
cancer)
Here, we analyze the gene expression profiles of early-onset colon
cancer mucosa versus control samples [35] to identify functional
groups that are enriched in differential gene expression. We then mine
these gene-sets for differentially expressed genes that have known
disease associations, or that may be new disease gene candidates, using
the query set post-analysis feature of the Enrichment Map software. Gene
expression data were scored for differentiality between cases and
controls using the t-test statistic; GSEA was used to generate
enrichment results, which were then visualized using Enrichment
Map, following the procedure described in U s ec a s e1 .K n o w nc o l o n
cancer genes were obtained from the DiseaseHub database (http://
zldev.ccbr.utoronto.ca/,ddong/diseaseHub/), which integrates data
from OMIM (Online Mendelian Inheritance in Man), GAD (Genetic
Association Database), HGMD (Human Gene Mutation Database),
PharmGKB (Pharmacogenomics Knowledge Base), CGP (Cancer
Genome Project) and GWAS (Genome Wide Association Studies).
Most of the disease genes in this database harbor rare mutations or
polymorphisms linked to colon cancer either by causation or by
statistical association. Overlap was scored using Fisher’s Exact Test p-
value. Nominal p-values (i.e. not adjusted) smaller than 10
24 were
deemed significant, and visualized as pink edges with thickness
indicating significance level (proportional to 2log (p-value)) (Figure 7).
Overall, the enrichment map has a smaller number of up-
regulated than down-regulated gene-sets (125 and 234, respective-
ly). Many down-regulated gene-sets map to metabolic processes,
with clusters relating to functions such as phospholipid and steroid
biosynthesis, metabolic cofactors, amino acid metabolism and
oxidative metabolism (specifically, citric acid cycle, mitochondrion,
electron transport chain). This is not surprising, as it is well known
that cancer cellsundergomajor metabolicshifts, such as the Warburg
Effect, consisting of dramatically reduced oxidative metabolism and
mitochondrial activity [36]. Compared to up-regulated gene-sets,
however, only a few down-regulated sets significantly overlap with
Figure 5. Enrichment map for estrogen treatment of breast cancer cells at 12 and 24 hours of culture. The map displays the enriched
gene-sets in estrogen-treated vs. untreated breast cancer cells at 12 and 24 hours of culture. Enrichments were mapped to the inner node area and to
the node borders, respectively. As in the previous figures, red represents enrichment in estrogen-treated cells (i.e. up-regulation after estrogen
treatment), whereas blue represents enrichment in untreated cells (i.e. down-regulation after estrogen treatment); color intensity is proportional to
enrichment significance. Clusters of functionally related gene-sets were manually circled and assigned a label.
doi:10.1371/journal.pone.0013984.g005
Enrichment Map
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observed in cancer is likely a downstream consequence of neoplastic
transformation, neither specific for colon cancer nor having a causal
role in its development. We decided to evaluate the gene expression
patterns of the three metabolic gene-sets with the most significant
connections to known disease genes: Iron ion binding (GO:0005506),
p-value 5.3610
213, in the Metal ion cluster binding cluster, Alkyl/aryl
transferase activity (GO:0016765, full name: Transferase activity,
transferring alkyl or aryl (other than methyl) groups) p-value
8.2610
211, in the Alkylation cluster, and Electron carrier activity
(GO:0009055), p-value 1.3610
210, in the Metabolic cofactor cluster.
Disease genes from Iron ion binding and Electron carrier activity are
highly overlapping (union size: 31, intersection size: 20), hence they
were considered together. Most of these genes belong to the
cytochrome P450 family (Table S2), which is important for
xenobiotic metabolism. Mutations in this gene family have been
associated with cancer either because of the impaired capability to
neutralize toxic chemicals, or because of the acquired capability to
activate the toxicity of otherwise inert compounds [37]. However,
none of the cytochrome P450 genes is characterized by marked up-
regulation or down-regulation (Table S2). On the other hand,
NQO1 (NAD(P)H dehydrogenase, quinone 1; EntrezGene ID: 1728),
whose inactivating mutation has been associated with colon cancer
in animal models and inhuman populationstudies [38], is markedly
down-regulated in cancer samples (t-test nominal p-value =
2.4610
26, 66.5% average reduction compared to control). Al-
though this gene is likely important for cancer progression and
severity, it was not identified in the original published gene
expression analysis. Inspection of Alkyl/aryl transferase activity revealed
thatmorethan90%ofthediseasegenesinthissetareglutathioneS-
transferases, involved in detoxification. Specifically, MGST1
(Microsomal glutathione S-transferase 1; EntrezGene ID: 4257) is
markedly down-regulated (t-test nominal p-value = 6.9610
25,
65.0% average reduction compared to control) and certain MGST1
polymorphisms have been associated with increased colon cancer
risk [39]. Like NQO1, this gene was not identified in the original
gene expression analysis. Similar results were also found for another
metabolic gene-set, Aromatic compound metabolic process (GO:0006725),
where the most down-regulated disease genes are glucuronosyltrans-
ferases. All in all, this type of analysis was useful to dissect the down-
regulationofspecificdetoxification enzymes fromthebroadersignal
of down-regulation of oxidative metabolism (Warburg Effect). The
biological relevance of the genes identified was supported by two
independent sources, namely differential expression in the micro-
array experiment analyzed and known disease associations based on
genetic screening or mechanistic studies. Therefore these genes
likely play an important role in colon cancer, and should be
considered for further study.
The up-regulated gene-sets with the highest overlap with known
disease genes are related to adhesion, angiogenesis, cell motility
and immune response. Among these, we focused on the gene-sets
Cell Motility and Chemotaxis. Dysregulation of these processes is
Figure 6. Heat-maps displaying gene-set expression patterns in the estrogen treatment experiment. Two gene-sets displaying different
enrichment patterns at 12 and 24 hours of the estrogen treatment experiment were selected from the enrichment map in Figure 5 and their
expression patterns were explored using heat maps within the Enrichment Map software. For APC-dependent protein degradation (left), there is a
marked increase of gene expression in estrogen treated cells at 24 hours compared to 12 hours, whereas the gene levels for untreated cells are
substantially the same at the two time points; the pattern observed is consistent with the presence of significant enrichment only at 24 hours. On the
other hand, for Replication fork (right), gene expression in estrogen treated cells at 12 and 24 hours is globally at similar levels, whereas there is an
increase of gene levels in untreated cells. This suggests an explanation of why Replication fork is enriched only at 12 hours.
doi:10.1371/journal.pone.0013984.g006
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infiltration into the lymph nodes in more advanced stages and
eventually metastasis [40,41]. We first looked at the Cell Motility
gene-set (GO:0051270), which is characterized by a very sig-
nificant overlap with the disease gene-set (nominal p-value:
3.3610
28). However, the disease genes in this set are only weakly
or inconsistently up-regulated (most significant nominal p-value:
1.8610
23). On the other hand, the Chemotaxis gene-set
(GO:0006935) has several known disease genes that are also
significantly up-regulated, even if its overall overlap significance
(2.5610
25) is weaker than for Cell Motility. Most of these genes are
chemokine ligands (Table S2), among which the most up-regulated
is CXCL12 (Chemokine (C-X-C motif) ligand 12 (stromal cell-derived factor
1), EntrezGene ID: 6387). CLXC12 is secreted by carcinoma-
associated fibroblasts, and is considered responsible for tumor
invasion [41]. Since this gene-set is likely important for colon
cancer, we also looked for differentially expressed genes that were
not in our disease gene-set. Interestingly, the top-ranking gene in
this group is CYR61 (Cysteine-rich, angiogenic inducer, 61; EntrezGene
ID: 3491), which was identified in the original study as one of the
seven genes with the most consistent differential expression
between colon cancer and control samples [35]. CYR61 could be
a good new candidate for disease association, as only two
publications relating CYR61 to colon cancer were found in
PubMed [35,42], one being the original publication of the
microarray data set used in this analysis. This shows how the
query set post-analysis feature of the Enrichment Map software can be
used to identify gene-sets associated with a biological condition
according to independent data sources (in this case, differential
gene expression and known disease genes), and then to mine these
sets for previously uncharacterized genes exhibiting interesting
patterns. The applicability of this feature is not restricted to disease
genes: it can also be used to identify the relations between the
targets of a known regulator (e.g. transcription factor, microRNA)
and the functional groups enriched in the condition(s) of interest.
Enrichment Map can be applied to any enrichment test
or gene set database
The previous use cases demonstrate the utility of Enrichment
Map to visualize GSEA enrichment results, using Gene Ontology
as gene-set source. However, Enrichment Map is compatible with
any type of enrichment test or gene-set source. In Text S2 we show
how it can be applied to a disease gene list, using Fisher’s Exact Test
to test a larger collection of gene-sets derived from Gene Ontology
Figure 7. Enrichment map for early-onset colon cancer and overlap with known disease genes. The map displays the enriched gene-sets
in early onset colon cancer patients vs. normal controls. The yellow triangle represents the set of known colon cancer genes from the DiseaseHub
database, which integrates disease gene lists from several genotype-phenotype association resources. Purple edges indicate overlap between the
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visualization with other available tools that are strictly dependent
on Fisher’s Exact Test.
Limitations of Enrichment Map
Enrichment map works well when enrichment results contain
many related gene sets. If only a few gene-sets result from
enrichment analysis, Enrichment Map does not provide much
benefit for result interpretation, as it is relatively easy to scan a list
of a few gene-sets. Further, if the resulting gene-sets are not highly
related, as they may be when not using Gene Ontology derived or
similarly hierarchically organized gene-sets, Enrichment Map will
not show clusters and thus will provide little benefit over a table of
gene-sets presentation format. In Text S3 we evaluate the
performance of Enrichment Map for several gene-set sources,
including experimentally- or computationally-derived gene-sets,
showing that Enrichment Map can be productively used in many
cases, even when Gene Ontology is not the major gene-set source.
However, specific gene-set sources, such as curated signatures
from gene expression experiments in Text S3, may have sparser
overlaps resulting in poorly connected networks.
Discussion
We have described Enrichment Map, a method for gene-set
enrichmentvisualization.EnrichmentMaporganizesenrichedgene-
sets in a network in a way that helps manage the large overlap
between gene-sets that often complicates interpretation of gene-set
enrichment results. Highly redundant or biologically related gene-
sets are placed close together, making enrichment results easier to
interpret. Gene-sets can be linked by various criteria, such as the
amount of co-expression of member genes, however the gene-set
overlap measure that we use has the advantage of being intuitive, as
biologically similar sets are clustered together, and general, as it does
not depend on the type of data being analyzed (e.g. gene expression
or genetic associations). We have demonstrated the utility of the
enrichmentmapvisualizationinanalyzingtwopublishedmicroarray
gene expression experiments, profiling the estrogen response in
breast cancer cells and early onset colon cancer. We showed that
Enrichment Map provides a concise and biologically meaningful
view of the cellular processes and components characterized by
differential expression.
Gene-setenrichmentisoftenusedtoanalyzesingleexperiments,or
single comparisons between two conditions within multi-condition
experiments, and meta-analysis of gene expression data are often
performed using Venn diagrams or heat-maps (for instance,
[33,43,44]), without exploiting the full potential of functional
annotations. Enrichment Map can be used for more informative
comparisons, identifying which functional groups differ between
experiments. A visualization framework is essential for this, as
traditional displays of enrichment require tedious and error prone
navigation of flat tables, often resulting in investigators choosing only
a handful of gene-sets for follow-up out of the thousands available to
them in a genomics experiment. The heat map view in Enrichment
Map enables the user to zoom in and explore an enriched gene-set in
more detail and the query set analysis facilitates exploration of
relations to known disease genes or regulatory modules.
Gene-set enrichment has been successfully applied to link
functional gene-sets to disease and other biological conditions in
hundreds of publications (accordingto ISI Web of Knowledge, October
2010, DAVID and GSEA were quoted by 159 and 1421 papers,
respectively). We have successfully applied Enrichment Map to
several research projects such as cardiac failure [45], thyroid cancer
signaling (Borrello MG, Degl’Innocenti D, Gariboldi M, Merico D,
Antoniotti M, Pierotti M, Unpublished work) and autism [46].
Virtually any research project in genomics can take advantage of
this visualization framework; in particular, the modular design of
the Enrichment Map Cytoscape plugin software makes it easy to
integrate within existing analysis workflows.
Future work will include incorporating molecular interaction
network and pathway information [47,48] into gene-set analysis
methods, as has successfully been done for gene expression analysis
[49,50,51,52,53]. We will also improve the visualization. For
instance, we are working on methods to automatically summarize
gene-set clusters using tag clouds (Oesper L, Merico D, Isserlin R,
Bader GD, Submitted work) and on better visualization methods
for multi-condition experiments (more than two enrichment
results). It will also be useful to develop gene set similarity
measures weighted to consider the most informative genes in the
gene set (such as the most differentially expressed).
Materials and Methods
Microarray data analysis
All microarray gene expression data were downloaded from the
NCBI GEO (Gene Expression Omnibus) database. The raw .CEL
files were processed with the rma statistical model for gene
expression signals, using the Bioconductor [54] affy package. The
data-sets were selected according to the following quality criteria:
reliable and high-coverage microarray platform (Affymetrix HGU-
133 plus 2.0), clear experimental design, sufficient number of
replicates ($3 for cell lines, $5 for patient samples), uniform cell
composition, Principal Component Analysis (PCA) results compatible
with the experimental design (i.e. clear separation of samples from
different classes). Enrichment analysis was performed after
conversion from Affymetrix to NCBI Entrez-Gene identifiers,
utilizing the Bioconductor hgu133plus2 package (downloaded March
2009).
Estrogen treatment of breast cancer cells. The
microarray data (GSE11352) were originally composed of 18
samples, with 3 replicates for every one of the 6 classes (3 time-
points for treated and untreated). The subset composed of the 12
and 24 hour time-points was analyzed using GSEA, t-test, 2000
gene-set permutations. The enrichment maps in use case 1 and 2
were generated using only the gene-sets satisfying these
enrichment thresholds: nominal p-value,0.001, FDR,5%. The
enrichment map overlap coefficient was set to 0.5.
Early Onset Colon Cancer. The microarray data
(GSE4107) are composed of 22 samples, with 10 normal and 12
colon cancer samples (colonic mucosa surgical samples). The data
set was analyzed using GSEA, t-test, 2000 gene-set permutations.
The enrichment map was generated using only the gene-sets
passing the following thresholds: nominal p-value,0.001,
FDR,5%. The overlap coefficient was set to 0.5.
Gene-set pre-processing
Human Gene Ontology (GO) [11] annotations were down-
loaded from Bioconductor, org.Hs.eg.db package (March 2009). In
order to maximize the coverage of GO annotations, no evidence
code based filter was applied. Terms annotating more than 500 or
less than 10 genes were discarded, resulting in 2378 GO terms
being used for the analysis. These thresholds are routinely used in
enrichment analysis as large gene-sets rarely convey much useful
biological meaning (e.g. regulation of physiological process), whereas
very small gene-sets are more susceptible to being falsely enriched
due to random fluctuations. Also, the reduced number of gene-sets
decreases the multiple testing correction burden, potentially
increasing the power of the analysis.
Enrichment Map
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visualization
Gene-set definition and enrichment table files are loaded in the
Enrichment Map Cytoscape plugin and filtered for significance,
according to the p-value and FDR thresholds set by the user. Overlap
between significant gene-sets is computed according to the Jaccard
coefficient or overlap coefficient, depending on the user’s choice.
Given sets A and B, and the cardinality operator ||where |X|
equals to the number of elements within set X, the Jaccard coefficient








The overlap coefficient is better when hierarchically-organized
gene-set collections (such as Gene Ontology) are included in the
analysis. Parent-child overlap produces the maximal score (1),
which means that all hierarchical relations will be present in the
network. On the other hand, the Jaccard coefficient tends to group
gene-sets with similar size, hence Gene Ontology parent-child
relations are often absent from the network. The gene-set network
is generated using only those interactions that pass a user-defined
threshold for the Overlap or Jaccard coefficient and it is arranged
using the Cytoscape force directed layout, weighted mode. The
Overlap or Jaccard coefficient defines the edge weights in this case.
Enrichment Map: implementation
Enriched Map was implemented as a Java plugin for the freely
available Cytoscape network visualization and analysis software
[26]. The plugin together with the source code is freely available at
http://baderlab.org/Software/EnrichmentMap under the GNU
LGPL license. The plugin reads two types of input formats, GSEA-
specific and generic. Heat-map visualization, as described in Use
case 2, is available for any selected gene-set. Any gene-set (or
collection of gene-sets) of user’s choice can be uploaded to perform
the query set post-analysis, as described in Use case 3.
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